Author Details

Makarenko, N P

Issue	Section	Title	File
Vol 2, No 2 (2000)	Articles	Problema osteoporoza i vozmozhnosti primeneniya miakal'tsika v onkologii	() () () () () ()
Vol 3, No 3 (2001)	Articles	Novye vozmozhnosti endokrinnoy terapii raka molochnoy zhelezy	() () () () () ()
Vol 3, No 3 (2001)	Articles	Perspektivy khimioterapii raka molochnoy zhelezy: vozmozhnosti gemzara po materialam ASCO 2001 g	() () () () () ()
Vol 6, No 1 (2004)	Articles	Fibrozno - kistoznaya bolezn'	() () () () () ()
Vol 6, No 2 (2004)	Articles	Novye aktsenty v endokrinnoy terapii raka molochnoy zhelezy	() () () () () ()
Vol 7, No 2 (2005)	Articles	Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy	() () () () () ()
Vol 11, No 1 (2009)	Articles	Effektivnost' Taksoterav neoad\"yuvantnoy i ad\"yuvantnoy khimioterapii raka molochnoy zhelezy (Po materialam mezhdunarodnykh issledovaniy)	() () () () () ()
Vol 11, No 2 (2009)	Articles	Rol' Taksotera v lechenii metastaticheskogo raka molochnoy zhelezy	() () () () () ()
Vol 12, No 1 (2010)	Articles	Mesto fulvestranta v endokrinoterapiimetastaticheskogo raka molochnoy zhelezy	() () () () () ()
Vol 13, No 3 (2011)	Articles	Osteopontin, CD55:prognosticheskie faktory riskapri rake molochnoy zhelezy	() () () () () ()
Vol 14, No 1 (2012)	Articles	Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie)	() () () () () ()
Vol 14, No 4 (2012)	Articles	Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy	() () () () () ()